Suraksha Diagnostic has completed the acquisition of 63% equity shares in Fetomat Wellness (Fetomat) for an amount not exceeding to Rs 5.19 crore, in cash. With the acquisition of 63% equity shares, Fetomat will become the subsidiary of the Company. This strategic acquisition will expand the Company’s service portfolio by integrating fetal medicine expertise into the existing healthcare framework of the Company. The synergies between the Company and Fetomat will enhance innovation in fetal medical diagnostics, strengthening the Company’s position in the industry.
Suraksha Diagnostic is primarily engaged in the business of running diagnostic centres for carrying out various pathological and radiological services.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: